Publications by authors named "Radu Dragomir"

Claim this Profile
C
Clinical Efficacy of Sodium Butyrate in Managing Pediatric Inflammatory Bowel Disease.
Adrian Goldiș, Radu Dragomir, Marina Adriana Mercioni, Diana Sirca, Christian Goldiș

Life (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Microbiome Modulation to Improve Clinical Outcomes in Pediatric Inflammatory Bowel Disease: A Multi-Omics and Interventional Approach.
Adrian Goldiș, Radu Dragomir, Marina Adriana Mercioni, Christian Goldiș, Diana Sirca

Microorganisms· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introducing a Novel Personalized Microbiome-Based Treatment for Inflammatory Bowel Disease: Results from NostraBiome's Internal Validation Study.
Adrian Goldiș, Radu Dragomir, Marina Adriana Mercioni, Christian Goldiș, Diana Sirca

Biomedicines· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence Algorithms in Predictive Factors for Hematologic Toxicities During Concurrent Chemoradiation for Cervical Cancer.
Ion Petre, Serban Negru, Radu Dragomir, Anca Bordianu, Izabella Petre

Cureus· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review on the Effectiveness and Outcomes of Nivolumab Treatment Schemes in Advanced and Metastatic Cervical Cancer.
Ion Petre, Corina Vernic, Izabella Petre, Cristian Sebastian Vlad, Simona Ioana Sipos, Radu Dumitru Dragomir

Diseases· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Influence of Age, Gender and Body Mass Index on Colorectal Cancer Location.
Dorel Popovici, Cristian Stanisav, Sorin Saftescu, Serban Negru, Radu Dragomir

Medicina (Kaunas)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between Body Mass Index and Prostate Cancer: The Impact on Progression-Free Survival.
Dorel Popovici, Cristian Stanisav, Marius Pricop, Radu Dragomir, Sorin Saftescu

Medicina (Kaunas)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antipsychotic polypharmacy in adult patients diagnosed with schizophrenia: A retrospective study.
Bogdan Patrichi, Cristiana Ţăpoi, Radu Ştefan Rogojină, Irina Bedreagă, Anca Dumitrache, Radu Dragomir

Exp Ther Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Experience and Predictive Factors Associated with Response in Platinum-Resistant Recurrent Ovarian Cancer: A Retrospective Single-Institution Study.
Radu Dragomir, Ioan Sas, Sorin Săftescu, Dorel Popovici, Roxana Margan, Adelina Silvana Dragomir

J Clin Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of metastatic topography for the immunotherapy of cutaneous and ocular melanomas.
Sorin Săftescu, Mihnea Munteanu, Dorel Popovici, Radu Dragomir, Alina Gabriela Negru

Rom J Ophthalmol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anthropometry in the immunotherapy of cutaneous and ocular melanomas.
Sorin Săftescu, Mihnea Munteanu, Dorel Popovici, Radu Dragomir, Maria Diana Dărăbuș

Rom J Ophthalmol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of the response to nivolumab immunotherapy in the second or subsequent lines for metastatic non-small cell lung cancers.
Sorin Săftescu, Șerban Negru, Simona Volovăț, Dorel Popovici, Vlad Chercota, Radu Dragomir

Exp Ther Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of combining neutrophil-to-lymphocyte ratio and pretreatment body mass index in predicting progression-free survival in patients with non-small cell lung cancer treated with nivolumab.
Radu Dragomir, Adelina Silvana Dragomir, Alina Negru, Sorin Săftescu, Dorel Popovici

Exp Ther Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis